A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began ...

A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

A large-scale study provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is just as effective as conventional radiotherapy for prostate cancer, without ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Since its European debut in 2021 [2], Radelumin has become a widely adopted tool for early detection, staging, and recurrence ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...